Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Names Chief Operating Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Evotec Names Chief Operating Officer

Dr. Ingrid Müller will oversee Evotec’s global operations and implementation of the Horizon initiative.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Evotec SE has appointed Dr. Ingrid Müller as Chief Operating Officer (COO) and a member of Evotec’s Management Board.

Müller offers more than 20 years of international leadership experience in the life sciences industry across operations, strategy, supply, procurement and R&D integration. In her role as COO, she will oversee Evotec’s global operations and implementation of the Horizon initiative, with a focus on quality, productivity, scalability, delivery, cost and the continued advancement of technological improvements across the business.

Dr. Christian Wojczewski, CEO of Evotec, said, “Ingrid has built a broad international leadership profile defined by strategic perspective, operational discipline and the ability to lead cross-functional execution and transformation. She joins Evotec at a pivotal time, contributing a highly complementary combination of operational, strategic and scientific understanding, as we continue to advance our growth transformation. Her expertise in operational efficiency and delivery will play a key part in the execution of our strategy in coming years. On behalf of the whole team, I’d like to welcome Ingrid to Evotec.”

Experience

Most recently, Müller served as Vice President Portfolio Strategy & Execution at CureVac. Prior to that, she held senior international leadership roles at Sanofi and Fresenius Kabi, where she was instrumental in strengthening supply resilience, implementing make-or-buy strategies, supporting growth and margin expansion, and delivering annual savings and cash-flow improvements.

Müller said, “I look forward to working with colleagues across the global organization to further strengthen operational excellence, quality and delivery for our partners, and to support Evotec’s next phase of focused and sustainable growth.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics